Cancer Research Donn Young Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Landen, C. N.
Right arrow Articles by Sood, A. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Landen, C. N., Jr.
Right arrow Articles by Sood, A. K.
[Cancer Research 65, 6910-6918, August 1, 2005]
© 2005 American Association for Cancer Research

Experimental Therapeutics, Molecular Targets, and Chemical Biology

Therapeutic EphA2 Gene Targeting In vivo Using Neutral Liposomal Small Interfering RNA Delivery

Charles N. Landen, Jr.1, Arturo Chavez-Reyes2, Corazon Bucana3, Rosemarie Schmandt1, Michael T. Deavers4, Gabriel Lopez-Berestein2 and Anil K. Sood1,3

Departments of 1 Gynecologic Oncology, 2 Experimental Therapeutics, 3 Cancer Biology, and 4 Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

Requests for reprints: Anil K. Sood, Departments of Gynecologic Oncology and Cancer Biology, The University of Texas M.D. Anderson Cancer Center, 1155 Herman Pressler, CPB6.3244, Unit 1362, Houston, TX 77030. Phone: 713-745-5266; Fax: 713-792-7586; E-mail: asood{at}mdanderson.org.

Inducing destruction of specific mRNA using small interfering RNA (siRNA) is a powerful tool in analysis of protein function, but its use as a therapeutic modality has been limited by inefficient or impractical delivery systems. We have used siRNA incorporated into the neutral liposome 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine (DOPC) for efficient in vivo siRNA delivery. In nude mice bearing i.p. ovarian tumors, nonsilencing siRNA tagged with the fluorochrome Alexa 555 was encapsulated into DOPC liposomes and shown to be taken up by the tumor as well as many major organs. Furthermore, DOPC-encapsulated siRNA targeting the oncoprotein EphA2 was highly effective in reducing in vivo EphA2 expression 48 hours after a single dose as measured by both Western blot and immunohistochemistry. Therapy experiments in an orthotopic mouse model of ovarian cancer were initiated 1 week after injection of either HeyA8 or SKOV3ip1 cell lines. Three weeks of treatment with EphA2-targeting siRNA-DOPC (150 µg/kg twice weekly) reduced tumor growth when compared with a nonsilencing siRNA (SKOV3ip1: 0.35 versus 0.70 g; P = 0.020; HeyA8: 0.98 versus 1.51 g; P = 0.16). When EphA2-targeting siRNA-DOPC was combined with paclitaxel, tumor growth was dramatically reduced compared with treatment with paclitaxel and a nonsilencing siRNA (SKOV3ip1: 0.04 versus 0.22 g; P < 0.001; HeyA8: 0.21 versus 0.84 g; P = 0.0027). These studies show the feasibility of siRNA as a clinically applicable therapeutic modality.




This article has been cited by other articles:


Home page
 J R Soc InterfaceHome page
S. Jiang, M. K. Gnanasammandhan, and Y. Zhang
Optical imaging-guided cancer therapy with fluorescent nanoparticles
J R Soc Interface, September 16, 2009; (2009) rsif.2009.0243v1.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. M. Brannan, W. Dong, L. Prudkin, C. Behrens, R. Lotan, B. N. Bekele, I. Wistuba, and F. M. Johnson
Expression of the Receptor Tyrosine Kinase EphA2 Is Increased in Smokers and Predicts Poor Survival in Non-Small Cell Lung Cancer
Clin. Cancer Res., July 1, 2009; 15(13): 4423 - 4430.
[Abstract] [Full Text] [PDF]

Home page
 Anticancer ResHome page
A. CHHABRA, A. VERMA, and K. MEHTA
Tissue Transglutaminase Promotes or Suppresses Tumors Depending on Cell Context
Anticancer Res, June 1, 2009; 29(6): 1909 - 1919.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L. S. Mangala, V. Zuzel, R. Schmandt, E. S. Leshane, J. B. Halder, G. N. Armaiz-Pena, W. A. Spannuth, T. Tanaka, M. M.K. Shahzad, Y. G. Lin, et al.
Therapeutic Targeting of ATP7B in Ovarian Carcinoma
Clin. Cancer Res., June 1, 2009; 15(11): 3770 - 3780.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J.-W. Lee, M. M.K. Shahzad, Y. G. Lin, G. Armaiz-Pena, L. S. Mangala, H.-D. Han, H.-S. Kim, E. J. Nam, N. B. Jennings, J. Halder, et al.
Surgical Stress Promotes Tumor Growth in Ovarian Carcinoma
Clin. Cancer Res., April 15, 2009; 15(8): 2695 - 2702.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
M. Kobel, C. B. Gilks, D. G. Huntsman, W. M. Merritt, D. L. Urbauer, and A. K. Sood
Dicer and Drosha in Ovarian Cancer
N. Engl. J. Med., March 12, 2009; 360(11): 1150 - 1151.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Parri, M. L. Taddei, F. Bianchini, L. Calorini, and P. Chiarugi
EphA2 Reexpression Prompts Invasion of Melanoma Cells Shifting from Mesenchymal to Amoeboid-like Motility Style
Cancer Res., March 1, 2009; 69(5): 2072 - 2081.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
W. M. Merritt, Y. G. Lin, L. Y. Han, A. A. Kamat, W. A. Spannuth, R. Schmandt, D. Urbauer, L. A. Pennacchio, J.-F. Cheng, A. M. Nick, et al.
Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer
N. Engl. J. Med., December 18, 2008; 359(25): 2641 - 2650.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Aleku, P. Schulz, O. Keil, A. Santel, U. Schaeper, B. Dieckhoff, O. Janke, J. Endruschat, B. Durieux, N. Roder, et al.
Atu027, a Liposomal Small Interfering RNA Formulation Targeting Protein Kinase N3, Inhibits Cancer Progression
Cancer Res., December 1, 2008; 68(23): 9788 - 9798.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
J. Wykosky and W. Debinski
The EphA2 Receptor and EphrinA1 Ligand in Solid Tumors: Function and Therapeutic Targeting
Mol. Cancer Res., December 1, 2008; 6(12): 1795 - 1806.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. J. Villares, M. Zigler, H. Wang, V. O. Melnikova, H. Wu, R. Friedman, M. C. Leslie, P. E. Vivas-Mejia, G. Lopez-Berestein, A. K. Sood, et al.
Targeting Melanoma Growth and Metastasis with Systemic Delivery of Liposome-Incorporated Protease-Activated Receptor-1 Small Interfering RNA
Cancer Res., November 1, 2008; 68(21): 9078 - 9086.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y. G. Lin, A. Immaneni, W. M. Merritt, L. S. Mangala, S. W. Kim, M. M.K. Shahzad, Y. T.M. Tsang, G. N. Armaiz-Pena, C. Lu, A. A. Kamat, et al.
Targeting Aurora Kinase with MK-0457 Inhibits Ovarian Cancer Growth
Clin. Cancer Res., September 1, 2008; 14(17): 5437 - 5446.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Y. Hwang, L. S. Mangala, J. Y. Fok, Y. G. Lin, W. M. Merritt, W. A. Spannuth, A. M. Nick, D. J. Fiterman, P. E. Vivas-Mejia, M. T. Deavers, et al.
Clinical and Biological Significance of Tissue Transglutaminase in Ovarian Carcinoma
Cancer Res., July 15, 2008; 68(14): 5849 - 5858.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
A. Soni, A. Akcakanat, G. Singh, D. Luyimbazi, Y. Zheng, D. Kim, A. Gonzalez-Angulo, and F. Meric-Bernstam
eIF4E knockdown decreases breast cancer cell growth without activating Akt signaling
Mol. Cancer Ther., July 1, 2008; 7(7): 1782 - 1788.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. Yang, S. R. Hamilton, A. Sood, T. Kuwai, L. Ellis, A. Sanguino, G. Lopez-Berestein, and D. D. Boyd
The Previously Undescribed ZKSCAN3 (ZNF306) Is a Novel "Driver" of Colorectal Cancer Progression
Cancer Res., June 1, 2008; 68(11): 4321 - 4330.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Verma, S. Guha, P. Diagaradjane, A. B. Kunnumakkara, A. M. Sanguino, G. Lopez-Berestein, A. K. Sood, B. B. Aggarwal, S. Krishnan, J. G. Gelovani, et al.
Therapeutic Significance of Elevated Tissue Transglutaminase Expression in Pancreatic Cancer
Clin. Cancer Res., April 15, 2008; 14(8): 2476 - 2483.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
W. M. Merritt, Y. G. Lin, W. A. Spannuth, M. S. Fletcher, A. A. Kamat, L. Y. Han, C. N. Landen, N. Jennings, K. De Geest, R. R. Langley, et al.
Effect of Interleukin-8 Gene Silencing With Liposome-Encapsulated Small Interfering RNA on Ovarian Cancer Cell Growth
J Natl Cancer Inst, March 5, 2008; 100(5): 359 - 372.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. N. Landen Jr, M. J. Birrer, and A. K. Sood
Early Events in the Pathogenesis of Epithelial Ovarian Cancer
J. Clin. Oncol., February 20, 2008; 26(6): 995 - 1005.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
M. J. Gray, G. Van Buren, N. A. Dallas, L. Xia, X. Wang, A. D. Yang, R. J. Somcio, Y. G. Lin, S. Lim, F. Fan, et al.
Therapeutic Targeting of Neuropilin-2 on Colorectal Carcinoma Cells Implanted in the Murine Liver
J Natl Cancer Inst, January 16, 2008; 100(2): 109 - 120.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Halder, Y. G. Lin, W. M. Merritt, W. A. Spannuth, A. M. Nick, T. Honda, A. A. Kamat, L. Y. Han, T. J. Kim, C. Lu, et al.
Therapeutic Efficacy of a Novel Focal Adhesion Kinase Inhibitor TAE226 in Ovarian Carcinoma
Cancer Res., November 15, 2007; 67(22): 10976 - 10983.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. N. Landen Jr., Y. G. Lin, G. N. Armaiz Pena, P. D. Das, J. M. Arevalo, A. A. Kamat, L. Y. Han, N. B. Jennings, W. A. Spannuth, P. H. Thaker, et al.
Neuroendocrine Modulation of Signal Transducer and Activator of Transcription-3 in Ovarian Cancer
Cancer Res., November 1, 2007; 67(21): 10389 - 10396.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. B. Nilsson, G. Armaiz-Pena, R. Takahashi, Y. G. Lin, J. Trevino, Y. Li, N. Jennings, J. Arevalo, S. K. Lutgendorf, G. E. Gallick, et al.
Stress Hormones Regulate Interleukin-6 Expression by Human Ovarian Carcinoma Cells through a Src-dependent Mechanism
J. Biol. Chem., October 12, 2007; 282(41): 29919 - 29926.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. N. Landen Jr., Y. G. Lin, A. Immaneni, M. T. Deavers, W. M. Merritt, W. A. Spannuth, D. C. Bodurka, D. M. Gershenson, W. R. Brinkley, and A. K. Sood
Overexpression of the Centrosomal Protein Aurora-A Kinase is Associated with Poor Prognosis in Epithelial Ovarian Cancer Patients
Clin. Cancer Res., July 15, 2007; 13(14): 4098 - 4104.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y. G. Lin, A. B. Kunnumakkara, A. Nair, W. M. Merritt, L. Y. Han, G. N. Armaiz-Pena, A. A. Kamat, W. A. Spannuth, D. M. Gershenson, S. K. Lutgendorf, et al.
Curcumin Inhibits Tumor Growth and Angiogenesis in Ovarian Carcinoma by Targeting the Nuclear Factor-{kappa}B Pathway
Clin. Cancer Res., June 1, 2007; 13(11): 3423 - 3430.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. A. Hammond, R. Lutterbuese, S. Roff, P. Lutterbuese, B. Schlereth, E. Bruckheimer, M. S. Kinch, S. Coats, P. A. Baeuerle, P. Kufer, et al.
Selective Targeting and Potent Control of Tumor Growth Using an EphA2/CD3-Bispecific Single-Chain Antibody Construct
Cancer Res., April 15, 2007; 67(8): 3927 - 3935.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
J. D. Wright and D. G. Mutch
Getting the Message Out: RNA Interference of Human Papillomavirus
Reproductive Sciences, January 1, 2007; 14(1): 6 - 7.
[PDF]

Home page
 JNCI J Natl Cancer InstHome page
C. N. Landen Jr., C. Lu, L. Y. Han, K. T. Coffman, E. Bruckheimer, J. Halder, L. S. Mangala, W. M. Merritt, Y. G. Lin, C. Gao, et al.
Efficacy and Antivascular Effects of EphA2 Reduction With an Agonistic Antibody in Ovarian Cancer.
J Natl Cancer Inst, November 1, 2006; 98(21): 1558 - 1570.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. Halder, A. A. Kamat, C. N. Landen Jr., L. Y. Han, S. K. Lutgendorf, Y. G. Lin, W. M. Merritt, N. B. Jennings, A. Chavez-Reyes, R. L. Coleman, et al.
Focal Adhesion Kinase Targeting Using In vivo Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy.
Clin. Cancer Res., August 15, 2006; 12(16): 4916 - 4924.
[Abstract] [Full Text] [PDF]

Home page
 aacredbookHome page
A. K. Sood, C. N. Landen, A. Sanguino, and G. Lopez-Berestein
Therapeutic gene silencing in vivo using RNA interference
Am. Assoc. Cancer Res. Educ. Book, April 1, 2006; 2006(1): 353 - 358.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. A. Kamat, M. Fletcher, L. M. Gruman, P. Mueller, A. Lopez, C. N. Landen Jr., L. Han, D. M. Gershenson, and A. K. Sood
The Clinical Relevance of Stromal Matrix Metalloproteinase Expression in Ovarian Cancer
Clin. Cancer Res., March 15, 2006; 12(6): 1707 - 1714.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. A. Hickson, D. Huo, D. J. Vander Griend, A. Lin, C. W. Rinker-Schaeffer, and S. D. Yamada
The p38 Kinases MKK4 and MKK6 Suppress Metastatic Colonization in Human Ovarian Carcinoma
Cancer Res., February 15, 2006; 66(4): 2264 - 2270.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.